Data search
Results for MligTC455_52061
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_52061 | 1829 | 38.10 | Mlig455_057385, Mlig455_057408, Mlig455_059550 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.420 Region-enriched R2: 1.691/0.03738 |
Mlig455_057385 {REF} {Length: 1281} {Pfam: Domain of unknown function (DUF4905) [PF16248.7, score=39.4]; Bacteriocin-protection, YdeI or OmpD-Associated [PF13376.8, score=36.7]} {RNA1509_18497} {RNA1310_73463} {RNA815_27286} Mlig455_057408 {REF} {Length: 2720} {Pfam: Domain of unknown function (DUF4905) [PF16248.7, score=38.6]; Bacteriocin-protection, YdeI or OmpD-Associated [PF13376.8, score=37.1]} {RNA1509_18497} {RNA1310_73463} {RNA815_27286} Mlig455_059550 {REF} {Length: 1173} {Pfam: Bacteriocin-protection, YdeI or OmpD-Associated [PF13376.8, score=33.3]; Domain of unknown function (DUF4905) [PF16248.7, score=30.1]} {RNA1509_18497} {RNA1310_73463} {RNA815_27286} |
Cumulative graph for MligTC455_52061
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -1.504 | 5.442 | 0.15673 | 0.77544 | |
| RegionR2 | 1.691 | 5.442 | 0.00219 | 0.03738 | |
| RegionR3 | -0.869 | 5.442 | 0.09761 | 0.54839 | |
| RegionR4 | 0.416 | 5.442 | 0.51000 | 0.83605 | |
| RegionR5 | -0.833 | 5.442 | 0.12099 | 0.34848 | |
| RegionR6 | 0.836 | 5.442 | 0.07867 | 0.51898 | |
| RegionR7 | -0.353 | 5.442 | 0.51396 | 1.00000 | |
| RegionR8 | 0.615 | 5.442 | 0.27579 | 0.90011 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -7.696 | 5.442 | 0.04414 | 0.67871 | |
| RegenerationR2 | -1.583 | 5.442 | 0.00973 | 0.15809 | |
| RegenerationR3 | -0.294 | 5.442 | 0.63861 | 0.92429 | |
| RegenerationR4 | -1.299 | 5.442 | 0.05362 | 0.37223 | |
| RegenerationR5 | 0.271 | 5.442 | 0.66397 | 0.93756 | |
| RegenerationR6 | -0.97 | 5.442 | 0.11541 | 0.41837 | |
| RegenerationBL | -1.555 | 5.442 | 0.01084 | 0.10533 | |
| RegenerationTP | -0.957 | 5.442 | 0.11671 | 0.52279 |
Genes with expression patterns similar to MligTC455_52061
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_52061 | 1829 | 38.1 | Mlig455_057385, Mlig455_057408, Mlig455_059550 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.420 Region-enriched R2: 1.691/0.03738 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_057385 {REF} {Length: 1281} {Pfam: Domain of unknown function (DUF4905) [PF16248.7, score=39.4]; Bacteriocin-protection, YdeI or OmpD-Associated [PF13376.8, score=36.7]} {RNA1509_18497} {RNA1310_73463} {RNA815_27286} Mlig455_057408 {REF} {Length: 2720} {Pfam: Domain of unknown function (DUF4905) [PF16248.7, score=38.6]; Bacteriocin-protection, YdeI or OmpD-Associated [PF13376.8, score=37.1]} {RNA1509_18497} {RNA1310_73463} {RNA815_27286} Mlig455_059550 {REF} {Length: 1173} {Pfam: Bacteriocin-protection, YdeI or OmpD-Associated [PF13376.8, score=33.3]; Domain of unknown function (DUF4905) [PF16248.7, score=30.1]} {RNA1509_18497} {RNA1310_73463} {RNA815_27286} |
|
| 2. | MligTC455_44025 | 591 | 12.31 | Mlig455_050980 | Neo: - Age: - Region-specific R2: 5.366 Region-enriched R2: 5.986/0.00000 |
4.258 | 0.733 | 0.906 | 0.751 | 0.955 | 0.913 | - | Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904} | |
| 3. | MligTC455_29317 | 89 | 1.85 | Mlig455_062533 | Neo: - Age: logFC(26M/2M)=0.866 |
SLC18A3 | 3.438 | - | 0.840 | 0.723 | 0.920 | 0.955 | - | Mlig455_062533 {REF} {Length: 3319} {Pfam: Major Facilitator Superfamily [PF07690.18, score=140.0]; LacY proton/sugar symporter [PF01306.21, score=22.0]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=457, Expect=1e-155]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=462, Expect=8e-158]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=512, Expect=6e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=474, Expect=6e-163]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=535, Expect=0.0]} {RNA1509_22907} {RNA1310_5498.1, RNA1509_22907} {RNA1509_22907, RNA815_3951} |
| 4. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
3.437 | - | 0.851 | 0.794 | 0.835 | 0.957 | - | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
| 5. | MligTC455_24407 | 222 | 4.63 | Mlig455_044026 | Neo: - Age: Down-Up-Up Region-specific R2: 3.725 Region-enriched R2: 3.414/0.00001 |
3.397 | - | 0.878 | 0.735 | 0.833 | 0.951 | - | Mlig455_044026 {REF} {Length: 503} {RNA1509_54091} {RNA1310_68348.1} {RNA815_33570.1} | |
| 6. | MligTC455_33772 | 104 | 2.17 | Mlig455_016493 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.862/0.00025 |
3.37 | - | 0.769 | 0.808 | 0.825 | 0.968 | - | Mlig455_016493 {REF} {Length: 883} {RNA1310_43848} {RNA815_55624} | |
| 7. | MligTC455_04854 | 57 | 1.18 | Mlig455_032030 | Neo: - Age: - Region-enriched R2: 5.099/0.03475 |
3.311 | - | 0.827 | 0.761 | 0.772 | 0.951 | - | Mlig455_032030 {REF} {Length: 1388} {RNA1310_84273} | |
| 8. | MligTC455_43454 | 36 | 0.74 | Mlig455_043999 | Neo: - Age: - |
2.662 | - | 0.885 | - | 0.826 | 0.951 | - | Mlig455_043999 {REF} {Length: 2456} {Dmel: FBgn0259222, CG42322, [RH, Score=101, Expect=3e-22]} {Smed: dd_Smed_v6_18554_0_1, dd_Smed_v6_18554_0_1, [Score=82.4, Expect=1e-17]} {RNA1310_20749} {RNA815_38231} | |
| 9. | MligTC455_43524 | 172 | 3.58 | Mlig455_031179 | Neo: - Age: - Region-enriched R2: 3.416/0.00534 |
SLC30A2 | 2.646 | - | 0.766 | - | 0.921 | 0.959 | - | Mlig455_031179 {REF} {Length: 2311} {Pfam: Cation efflux family [PF01545.23, score=155.3]; Dimerisation domain of Zinc Transporter [PF16916.7, score=21.1]} {Human: ENSG00000158014, SLC30A2, solute carrier family 30 member 2, [Score=350, Expect=3e-117]} {Mouse: ENSMUSG00000028836, Slc30a2, solute carrier family 30 (zinc transporter), member 2, [Score=362, Expect=3e-122]} {Dmel: FBgn0028516, ZnT35C, Zinc transporter 35C, [RH, Score=324, Expect=1e-106]} {Celegans: WBGene00011821, cdf-2, Cation Diffusion Facilitator family, [RH, Score=324, Expect=7e-108]} {Smed: dd_Smed_v6_5529_0_1, dd_Smed_v6_5529_0_1, [Score=432, Expect=4e-150]} {RNA1509_37229} {RNA1310_13324.1} {RNA815_5520} |
| 10. | MligTC455_19252 | 1355 | 28.24 | Mlig455_054908, Mlig455_065614, Mlig455_065623 | Neo: - Age: Down-Down-Up Region-enriched R2: 4.927/0.00706 |
QPCT | 2.624 | - | 0.879 | 0.795 | - | 0.950 | - | Mlig455_054908 {REF} {Length: 1427} {Pfam: Peptidase family M28 [PF04389.19, score=84.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=113, Expect=3e-28]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=123, Expect=8e-32]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=116, Expect=7e-30]} {Celegans: WBGene00010418, H27A22.1, [Score=124, Expect=6e-33]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=118, Expect=1e-30]} {RNA1509_35784} {RNA1310_28475} Mlig455_065614 {REF} {Length: 1515} {Pfam: Peptidase family M28 [PF04389.19, score=121.0]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=157, Expect=2e-44]} {Mouse: ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=162, Expect=2e-46]; ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=161, Expect=6e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=158, Expect=2e-45]} {Celegans: WBGene00010418, H27A22.1, [Score=166, Expect=2e-48]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=156, Expect=2e-44]} {RNA1509_35784} {RNA1310_28475, RNA1509_35784} Mlig455_065623 {REF} {Length: 1295} {Pfam: Peptidase family M28 [PF04389.19, score=121.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=158, Expect=6e-45]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=162, Expect=2e-46]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=161, Expect=3e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=154, Expect=8e-44]} {Celegans: WBGene00010418, H27A22.1, [Score=163, Expect=2e-47]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=154, Expect=8e-44]} {RNA1509_35784} {RNA1310_28475} |
| 11. | MligTC455_50602 | 84 | 1.74 | Mlig455_065088 | Neo: - Age: - |
2.617 | - | - | 0.791 | 0.951 | 0.875 | - | Mlig455_065088 {REF} {Length: 2765} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=129.5]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=67.8, Expect=6e-12]} {RNA1310_8235} {RNA815_10456.1} | |
| 12. | MligTC455_20028 | 492 | 10.25 | Mlig455_060293, Mlig455_065638 | Neo: - Age: logFC(26M/2M)=-0.541 Region-enriched R2: 1.959/0.01794 |
LRRC55 | 2.599 | - | - | 0.740 | 0.893 | 0.966 | - | Mlig455_060293 {REF} {Length: 2403} {Pfam: Leucine rich repeat [PF13855.8, score=64.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=21.3]} {Human: ENSG00000183908, LRRC55, leucine rich repeat containing 55, [Score=59.7, Expect=4e-09]; ENSG00000171236, LRG1, leucine rich alpha-2-glycoprotein 1, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000075224, Lrrc55, leucine rich repeat containing 55, [Score=58.5, Expect=6e-09]; ENSMUSG00000020105, Lrig3, leucine-rich repeats and immunoglobulin-like domains 3, [Score=57.0, Expect=4e-08]} {Dmel: FBgn0033250, CG14762, [Score=63.2, Expect=2e-10]} {RNA1509_43260} {RNA1310_15302, RNA1509_43260} {RNA1509_43260, RNA815_13279} Mlig455_065638 {REF} {Length: 2056} {Pfam: Leucine rich repeat [PF13855.8, score=62.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=21.6]} {Human: ENSG00000183908, LRRC55, leucine rich repeat containing 55, [Score=61.2, Expect=1e-09]} {Mouse: ENSMUSG00000075224, Lrrc55, leucine rich repeat containing 55, [Score=60.1, Expect=2e-09]} {Dmel: FBgn0033250, CG14762, [Score=62.4, Expect=5e-10]} {RNA1509_43260} {RNA1310_15302} {RNA815_13279} |
| 13. | MligTC455_19616 | 70 | 1.46 | Mlig455_045100 | Neo: - Age: - |
RPH3A | 2.593 | - | 0.747 | - | 0.890 | 0.956 | - | Mlig455_045100 {REF} {Length: 2276} {Pfam: C2 domain [PF00168.32, score=141.3]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=247, Expect=9e-73]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=244, Expect=9e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [Score=179, Expect=2e-50]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=209, Expect=6e-58]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=216, Expect=3e-62]} {RNA1310_30378} {RNA815_36857} |
| 14. | MligTC455_43642 | 2199 | 45.81 | Mlig455_018475 | Neo: - Age: Down-Up-Up Region-specific R2: 2.701 Region-enriched R2: 2.110/0.00000 |
2.587 | - | 0.885 | - | 0.752 | 0.950 | - | Mlig455_018475 {REF} {Length: 949} {RNA1509_30521} {RNA1310_47277.3, RNA1509_30521} {RNA1509_30521, RNA815_19145.1} | |
| 15. | MligTC455_12037 | 183 | 3.81 | Mlig455_016647, Mlig455_016711 | Neo: - Age: Down-Up-Up |
DYNLL1 | 2.586 | 0.955 | - | - | 0.700 | 0.931 | - | Mlig455_016647 {REF} {Length: 879} {Pfam: Dynein light chain type 1 [PF01221.20, score=69.4]} {Human: ENSG00000088986, DYNLL1, dynein light chain LC8-type 1, [Score=62.8, Expect=7e-14]; ENSG00000264364, DYNLL2, dynein light chain LC8-type 2, [Score=60.1, Expect=7e-13]} {Mouse: ENSMUSG00000009013, Dynll1, dynein light chain LC8-type 1, [Score=62.8, Expect=4e-14]; ENSMUSG00000020483, Dynll2, dynein light chain LC8-type 2, [Score=60.1, Expect=5e-13]} {Dmel: FBgn0011760, ctp, cut up, [Score=60.5, Expect=2e-13]} {Celegans: WBGene00001005, dlc-1, Dynein light chain 1, cytoplasmic, [Score=59.3, Expect=6e-13]} {Smed: dd_Smed_v6_10084_0_2, dd_Smed_v6_10084_0_2, [Score=65.9, Expect=1e-15]} {RNA1509_36890} {RNA1310_30005} {RNA815_41098} Mlig455_016711 {REF} {Length: 890} {Pfam: Dynein light chain type 1 [PF01221.20, score=69.4]} {Human: ENSG00000088986, DYNLL1, dynein light chain LC8-type 1, [Score=62.8, Expect=5e-14]; ENSG00000264364, DYNLL2, dynein light chain LC8-type 2, [Score=60.1, Expect=7e-13]} {Mouse: ENSMUSG00000009013, Dynll1, dynein light chain LC8-type 1, [Score=62.8, Expect=4e-14]; ENSMUSG00000020483, Dynll2, dynein light chain LC8-type 2, [Score=60.1, Expect=5e-13]} {Dmel: FBgn0011760, ctp, cut up, [Score=60.8, Expect=2e-13]} {Celegans: WBGene00001005, dlc-1, Dynein light chain 1, cytoplasmic, [Score=59.3, Expect=5e-13]} {Smed: dd_Smed_v6_10084_0_5, dd_Smed_v6_10084_0_5, [Score=65.9, Expect=1e-15]} {RNA1509_36890} {RNA1310_30005} {RNA815_41098} |
| 16. | MligTC455_31172 | 195 | 4.06 | Mlig455_028354 | Neo: - Age: - Region-enriched R5: 4.005/0.04475 |
2.572 | - | - | - | 0.799 | 0.953 | 0.820 | Mlig455_028354 {REF} {Length: 2036} {RNA1310_45498} {RNA815_15412} | |
| 17. | MligTC455_52210 | 5661 | 117.93 | Mlig455_005609, Mlig455_014449, Mlig455_070190 | Neo: - Age: - |
2.542 | 0.710 | 0.867 | 0.965 | - | - | - | Mlig455_005609 {REF} {Length: 747} {Pfam: Domain of unknown function (DUF4573) [PF15140.8, score=23.9]} {RNA1509_54058} {RNA1310_50049} {RNA815_23688.1} Mlig455_014449 {REF} {Length: 881} {Pfam: Domain of unknown function (DUF4573) [PF15140.8, score=22.6]} {RNA1509_54058} {RNA1310_50296} {RNA815_23688.1} Mlig455_070190 {REF} {Length: 692} {Pfam: Domain of unknown function (DUF4573) [PF15140.8, score=20.8]} {RNA1509_54058} {RNA1310_50296} {RNA815_23688.2} |
|
| 18. | MligTC455_19277 | 1013 | 21.11 | Mlig455_059600 | Neo: - Age: - Region-specific R2: 4.883 Region-enriched R2: 5.766/0.00000 |
2.52 | 0.960 | 0.814 | 0.746 | - | - | - | Mlig455_059600 {REF} {Length: 827} {NoTransDecoderORF} {RNA1509_43907} {RNA1310_81348} | |
| 19. | MligTC455_25920 | 378 | 7.87 | Mlig455_006540 | Neo: - |
2.512 | - | 0.740 | - | 0.810 | 0.962 | - | Mlig455_006540 {REF} {Length: 1697} {RNA1509_12380} {RNA1310_42539} {RNA815_19957} | |
| 20. | MligTC455_29412 | 46 | 0.96 | Mlig455_000627, Mlig455_008268, Mlig455_040614 | Neo: - Age: Up-Down-Up |
2.508 | - | 0.750 | - | 0.807 | 0.951 | - | Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942} Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1} Mlig455_040614 {REF} {Length: 1016} |
|
| 21. | MligTC455_08333 | 172 | 3.59 | Mlig455_025435, Mlig455_025445 | Neo: - Age: - |
TNS1 | 2.476 | - | 0.724 | - | 0.791 | 0.961 | - | Mlig455_025435 {REF} {Length: 4797} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=67.1]; C2 domain of PTEN tumour-suppressor protein [PF10409.11, score=38.4]; SH2 domain [PF00017.26, score=36.5]} {Human: ENSG00000079308, TNS1, tensin 1, [RH, Score=257, Expect=2e-69]; ENSG00000136205, TNS3, tensin 3, [RH, Score=251, Expect=1e-67]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [RH, Score=256, Expect=1e-72]; ENSMUSG00000020422, Tns3, tensin 3, [RH, Score=251, Expect=1e-67]} {Dmel: FBgn0000244, by, blistery, [RH, Score=222, Expect=2e-60]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=243, Expect=6e-72]} {Smed: dd_Smed_v6_4454_0_2, dd_Smed_v6_4454_0_2, [Score=217, Expect=5e-59]} {RNA1509_43365} {RNA1310_7714, RNA1509_43365} {RNA1509_43365, RNA815_14514} Mlig455_025445 {REF} {Length: 1758} {Pfam: C2 domain of PTEN tumour-suppressor protein [PF10409.11, score=37.0]} {Human: ENSG00000079308, TNS1, tensin 1, [RH, Score=191, Expect=2e-53]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=191, Expect=3e-51]; ENSMUSG00000037003, Tns2, tensin 2, [Score=187, Expect=4e-50]} {Dmel: FBgn0026379, Pten, Phosphatase and tensin homolog, [Score=67.8, Expect=1e-11]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=109, Expect=1e-24]} {RNA1509_44169} {RNA1310_10509} {RNA815_24170} |
| 22. | MligTC455_51238 | 58 | 1.21 | Mlig455_011511 | Neo: - Age: - |
KCNMA1 | 2.465 | - | - | 0.777 | 0.730 | 0.958 | - | Mlig455_011511 {REF} {Length: 2300} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=100.8]; Ion channel [PF07885.18, score=29.2]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=272, Expect=4e-80]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=271, Expect=4e-79]} {Dmel: FBgn0003429, slo, slowpoke, [Score=180, Expect=8e-48]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=269, Expect=9e-79]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=294, Expect=9e-88]} {RNA1310_5274} {RNA815_44227} |
| 23. | MligTC455_35739 | 91 | 1.9 | Mlig455_050779 | Neo: - Age: Up-Down-Down |
ADGRL2 | 2.429 | - | 0.755 | - | 0.719 | 0.955 | - | Mlig455_050779 {REF} {Length: 4277} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=110.1]; Pentaxin family [PF00354.19, score=43.4]; Hormone receptor domain [PF02793.24, score=35.9]; Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=33.0]; GPCR-Autoproteolysis INducing (GAIN) domain [PF16489.7, score=20.5]; Myc amino-terminal region [PF01056.20, score=18.8]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=140, Expect=5e-33]; ENSG00000072071, ADGRL1, adhesion G protein-coupled receptor L1, [RH, Score=139, Expect=2e-32]; ENSG00000150471, ADGRL3, adhesion G protein-coupled receptor L3, [RH, Score=133, Expect=9e-31]} {Mouse: ENSMUSG00000028184, Adgrl2, adhesion G protein-coupled receptor L2, [RH, Score=142, Expect=1e-33]; ENSMUSG00000013033, Adgrl1, adhesion G protein-coupled receptor L1, [RH, Score=140, Expect=6e-33]} {Celegans: WBGene00002252, lat-2, Latrophilin-like protein LAT-2, [RH, Score=124, Expect=2e-28]} {Smed: dd_Smed_v6_16446_0_2, dd_Smed_v6_16446_0_2, [RH, Score=444, Expect=1e-139]} {RNA1509_25495} {RNA1310_3070} {RNA815_2153} |
| 24. | MligTC455_41448 | 192 | 4.01 | Mlig455_066626 | Neo: - Age: - Region-specific R2: 6.449 Region-enriched R2: 4.988/0.02499 |
2.399 | - | - | 0.720 | 0.703 | 0.976 | - | Mlig455_066626 {REF} {Length: 987} {Pfam: F5/8 type C domain [PF00754.27, score=25.0]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=52.4, Expect=8e-09]} {RNA1509_36923} {RNA1310_37535} {RNA815_20943} | |
| 25. | MligTC455_11254 | 19 | 0.4 | Mlig455_060079 | Neo: - Age: - |
1.877 | - | - | - | 0.911 | 0.966 | - | Mlig455_060079 {REF} {Length: 1689} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} | |
| 26. | MligTC455_43258 | 756 | 15.75 | Mlig455_027531 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=0.347 Region-enriched R2: 1.796/0.01868 Regeneration-downregulated BL: -3.121 Regeneration-depleted BL: -3.121 |
1.849 | - | 0.962 | - | 0.887 | - | - | Mlig455_027531 {REF} {Length: 695} {RNA1509_24629} {RNA1310_43299, RNA1509_24629} {RNA1509_24629, RNA815_28702} | |
| 27. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 1.843 | - | - | - | 0.885 | 0.958 | - | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
| 28. | MligTC455_18505 | 15 | 0.31 | Mlig455_017536 | Neo: - Age: - |
1.837 | - | - | - | 0.877 | 0.960 | - | Mlig455_017536 {REF} {Length: 2174} {RNA1310_61282} {RNA815_41334} | |
| 29. | MligTC455_50491 | 751 | 15.65 | Mlig455_012096 | Neo: - Age: - Region-enriched R2: 1.944/0.00216 |
FAP | 1.831 | - | - | - | 0.873 | 0.958 | - | Mlig455_012096 {REF} {Length: 1121} {Pfam: Prolyl oligopeptidase family [PF00326.23, score=66.9]} {Human: ENSG00000078098, FAP, fibroblast activation protein alpha, [Score=87.4, Expect=4e-20]} {Mouse: ENSMUSG00000000392, Fap, fibroblast activation protein, [Score=84.7, Expect=2e-19]} {Dmel: FBgn0031741, CG11034, [Score=87.0, Expect=3e-20]} {Celegans: WBGene00001055, dpf-2, Dipeptidyl peptidase family member 2, [Score=77.0, Expect=6e-17]} {Smed: dd_Smed_v6_9183_0_1, dd_Smed_v6_9183_0_1, [Score=102, Expect=7e-26]} {RNA1509_12435} {RNA1310_3631.1} {RNA815_1805} |
| 30. | MligTC455_22125 | 178 | 3.71 | Mlig455_028579, Mlig455_028597 | Neo: - Age: - Region-enriched R2: 5.949/0.00261 |
1.786 | - | - | - | 0.836 | 0.950 | - | Mlig455_028579 {REF} {Length: 993} {RNA1509_54214} {RNA1310_51652} {RNA815_36975} Mlig455_028597 {REF} {Length: 962} {RNA1509_54214} {RNA1310_51652} {RNA815_36975} |
|
| 31. | MligTC455_53251 | 67 | 1.4 | Mlig455_018510 | Neo: - Age: logFC(26M/2M)=0.877 Region-enriched R2: 4.210/0.03685 |
SYT7 | 1.779 | - | - | - | 0.823 | 0.956 | - | Mlig455_018510 {REF} {Length: 3473} {Pfam: C2 domain [PF00168.32, score=157.9]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=261, Expect=1e-79]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=251, Expect=2e-77]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [Score=233, Expect=6e-74]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=179, Expect=4e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=194, Expect=1e-57]} {RNA1509_49257} {RNA1310_13701} {RNA815_8339} |
| 32. | MligTC455_18091 | 71 | 1.49 | Mlig455_014664 | Neo: - Age: - |
ARL3 | 1.765 | - | - | - | 0.793 | 0.972 | - | Mlig455_014664 {REF} {Length: 1771} {Pfam: ADP-ribosylation factor family [PF00025.23, score=67.3]; 50S ribosome-binding GTPase [PF01926.25, score=26.6]; G-protein alpha subunit [PF00503.22, score=19.1]} {Human: ENSG00000138175, ARL3, ADP ribosylation factor like GTPase 3, [Score=67.8, Expect=2e-13]; ENSG00000122644, ARL4A, ADP ribosylation factor like GTPase 4A, [Score=67.8, Expect=3e-13]; ENSG00000143761, ARF1, ADP ribosylation factor 1, [Score=65.5, Expect=1e-12]; ENSG00000168374, ARF4, ADP ribosylation factor 4, [Score=65.1, Expect=2e-12]; ENSG00000134287, ARF3, ADP ribosylation factor 3, [Score=65.1, Expect=2e-12]; ENSG00000188042, ARL4C, ADP ribosylation factor like GTPase 4C, [Score=64.7, Expect=4e-12]} {Mouse: ENSMUSG00000047446, Arl4a, ADP-ribosylation factor-like 4A, [Score=67.4, Expect=2e-13]; ENSMUSG00000025035, Arl3, ADP-ribosylation factor-like 3, [Score=66.6, Expect=4e-13]; ENSMUSG00000048076, Arf1, ADP-ribosylation factor 1, [Score=65.5, Expect=1e-12]; ENSMUSG00000051853, Arf3, ADP-ribosylation factor 3, [Score=65.1, Expect=1e-12]; ENSMUSG00000049866, Arl4c, ADP-ribosylation factor-like 4C, [Score=64.3, Expect=3e-12]} {Dmel: FBgn0013749, Arf102F, ADP ribosylation factor at 102F, [Score=66.6, Expect=3e-13]} {Celegans: WBGene00000184, arf-6, ADP-Ribosylation Factor related, [Score=65.5, Expect=5e-13]} {Smed: dd_Smed_v6_2013_0_1, dd_Smed_v6_2013_0_1, [Score=78.6, Expect=7e-18]} {RNA1310_41790} {RNA815_35492} |
| 33. | MligTC455_54197 | 356 | 7.43 | Mlig455_020677, Mlig455_048758, Mlig455_059268 | Neo: - Age: - |
HVCN1 | 1.754 | - | - | - | 0.802 | 0.952 | - | Mlig455_020677 {REF} {Length: 2901} {Pfam: Ion transport protein [PF00520.33, score=23.6]} {Human: ENSG00000122986, HVCN1, hydrogen voltage gated channel 1, [Score=67.0, Expect=2e-11]} {Mouse: ENSMUSG00000064267, Hvcn1, hydrogen voltage-gated channel 1, [Score=66.2, Expect=2e-11]} {Smed: dd_Smed_v6_20053_0_1, dd_Smed_v6_20053_0_1, [Score=300, Expect=3e-94]} {RNA1310_10343} {RNA815_20707} Mlig455_048758 {REF} {Length: 1647} {Smed: dd_Smed_v6_16233_0_1, dd_Smed_v6_16233_0_1, [Score=88.2, Expect=1e-19]} {RNA1310_11204} {RNA815_20707} Mlig455_059268 {REF} {Length: 2414} {Pfam: Ion transport protein [PF00520.33, score=23.7]} {Human: ENSG00000122986, HVCN1, hydrogen voltage gated channel 1, [Score=67.4, Expect=1e-11]} {Mouse: ENSMUSG00000064267, Hvcn1, hydrogen voltage-gated channel 1, [Score=65.9, Expect=2e-11]} {Smed: dd_Smed_v6_20053_0_1, dd_Smed_v6_20053_0_1, [Score=298, Expect=1e-93]} {RNA1310_11204} {RNA815_20707} |
| 34. | MligTC455_42530 | 41 | 0.86 | Mlig455_064531 | Neo: - Age: - |
RASL12 | 1.749 | - | - | - | 0.783 | 0.966 | - | Mlig455_064531 {REF} {Length: 4677} {Pfam: Ras family [PF00071.24, score=65.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=24.9]} {Human: ENSG00000103710, RASL12, RAS like family 12, [Score=88.6, Expect=3e-20]; ENSG00000134533, RERG, RAS like estrogen regulated growth inhibitor, [Score=87.4, Expect=3e-20]} {Mouse: ENSMUSG00000092164, Rergl, RERG/RAS-like, [Score=89.4, Expect=3e-21]; ENSMUSG00000030222, Rerg, RAS-like, estrogen-regulated, growth-inhibitor, [Score=87.4, Expect=2e-20]} {Dmel: FBgn0035711, CG8519, [Score=88.6, Expect=6e-21]} {Celegans: WBGene00021811, ral-1, RAL (Ras-related GTPase) homolog, [Score=65.5, Expect=2e-12]} {Smed: dd_Smed_v6_7273_0_1, dd_Smed_v6_7273_0_1, [Score=87.8, Expect=6e-21]} {RNA1310_147102} |
| 35. | MligTC455_16526 | 125 | 2.61 | Mlig455_026747, Mlig455_051738, Mlig455_051739, Mlig455_051760 | Neo: - Age: Up-Down-Down |
GABRG3 | 1.748 | - | 0.787 | - | - | 0.961 | - | Mlig455_026747 {REF} {Length: 6317} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=31.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=25.1]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=57.8, Expect=4e-08]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=57.4, Expect=5e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=60.8, Expect=3e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=49.3, Expect=7e-06]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=517, Expect=2e-177]} {RNA1310_24908.1} {RNA815_12627} Mlig455_051738 {REF} {Length: 1364} {RNA1310_43175} {RNA815_39065} Mlig455_051739 {REF} {Length: 2058} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.3]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=58.9, Expect=1e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=62.8, Expect=5e-10]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=532, Expect=0.0]} {RNA1310_16047} {RNA815_12627} Mlig455_051760 {REF} {Length: 5962} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.2]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=72.8, Expect=5e-13]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=69.7, Expect=5e-12]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=77.0, Expect=2e-14]} {Dmel: FBgn0030707, CG8916, [Score=60.5, Expect=2e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=57.8, Expect=1e-08]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [RH, Score=573, Expect=0.0]} {RNA1310_24908.1} {RNA815_12627} |
| 36. | MligTC455_18955 | 13 | 0.27 | Mlig455_047126 | Neo: - Age: - |
1.746 | - | - | 0.793 | - | 0.953 | - | Mlig455_047126 {REF} {Length: 1058} | |
| 37. | MligTC455_39463 | 228 | 4.76 | Mlig455_025914, Mlig455_025946 | Neo: - Age: - Regeneration-downregulated R4: -3.846 Regeneration-depleted R4: -3.846 |
1.744 | - | - | - | 0.779 | 0.965 | - | Mlig455_025914 {REF} {Length: 1257} {RNA1310_37139.1} {RNA815_50944} Mlig455_025946 {REF} {Length: 2808} {tRNA: Ala(CGC),pseudo, score=22.1} {Pfam: Lectin C-type domain [PF00059.23, score=35.2]} {Smed: dd_Smed_v6_84586_0_1, dd_Smed_v6_84586_0_1, [RH, Score=53.1, Expect=4e-09]} {RNA1509_4810} {RNA1310_37139.1} {RNA815_40603} |
|
| 38. | MligTC455_32612 | 55 | 1.15 | Mlig455_015630 | Neo: - Age: - Region-enriched R2: 5.626/0.02523 |
ARX | 1.738 | - | - | - | 0.773 | 0.965 | - | Mlig455_015630 {REF} {Length: 2012} {Pfam: Homeodomain [PF00046.31, score=83.5]} {Human: ENSG00000004848, ARX, aristaless related homeobox, [RH, Score=134, Expect=1e-34]} {Mouse: ENSMUSG00000035277, Arx, aristaless related homeobox, [RH, Score=133, Expect=1e-34]} {Dmel: FBgn0000061, al, aristaless, [RH, Score=130, Expect=3e-34]} {Celegans: WBGene00044330, alr-1, AristaLess (Drosophila homeodomain) Related, [RH, Score=118, Expect=2e-30]} {Smed: dd_Smed_v6_63359_0_1, dd_Smed_v6_63359_0_1, [Score=119, Expect=3e-33]} {RNA1310_42333.1} {RNA815_48205} |
| 39. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 1.726 | - | - | - | 0.755 | 0.971 | - | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
| 40. | MligTC455_43950 | 2296 | 47.84 | Mlig455_029261, Mlig455_035647, Mlig455_035748 | Neo: - Age: - Regeneration-downregulated BL: -2.094 Regeneration-depleted BL: -2.094 |
1.721 | - | - | - | 0.771 | 0.950 | - | Mlig455_029261 {REF} {Length: 2798} {RNA1509_28538, RNA1509_39513, RNA1509_9241} {RNA1310_10383, RNA1509_28538, RNA1509_39513, RNA1509_9241} {RNA1509_28538, RNA1509_39513, RNA1509_9241, RNA815_3519} Mlig455_035647 {REF} {Length: 2505} {RNA1509_9241} {RNA1310_10383} {RNA815_3519} Mlig455_035748 {REF} {Length: 2496} {RNA1509_9241} {RNA1310_10383} {RNA815_3519} |
|
| 41. | MligTC455_29318 | 93 | 1.93 | Mlig455_068579 | Neo: - Age: logFC(26M/2M)=-0.605 |
SLC18A3 | 1.716 | - | - | - | 0.761 | 0.955 | - | Mlig455_068579 {REF} {Length: 3048} {Pfam: Major Facilitator Superfamily [PF07690.18, score=131.7]; LacY proton/sugar symporter [PF01306.21, score=23.8]; PUCC protein [PF03209.17, score=21.8]; MFS_1 like family [PF12832.9, score=19.1]; Sugar (and other) transporter [PF00083.26, score=18.5]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [Score=393, Expect=3e-132]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [Score=395, Expect=3e-133]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [Score=434, Expect=6e-148]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [Score=392, Expect=2e-132]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [Score=452, Expect=6e-156]} {RNA1509_22907} {RNA1310_5498.1} {RNA815_3951} |
| 42. | MligTC455_41512 | 268 | 5.59 | Mlig455_057018 | Neo: - Age: Down-Down-Up |
HMCN2 | 1.71 | - | - | - | 0.757 | 0.953 | - | Mlig455_057018 {REF} {Length: 2115} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=167.2]; Immunoglobulin domain [PF13927.8, score=124.8]; Immunoglobulin domain [PF13895.8, score=78.7]; Immunoglobulin domain [PF00047.27, score=77.2]; Immunoglobulin V-set domain [PF07686.19, score=45.1]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=40.4]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=83.6, Expect=3e-16]; ENSG00000138347, MYPN, myopalladin, [Score=82.8, Expect=4e-16]; ENSG00000129116, PALLD, palladin, cytoskeletal associated protein, [Score=82.4, Expect=4e-16]; ENSG00000072195, SPEG, SPEG complex locus, [Score=82.0, Expect=6e-16]} {Mouse: ENSMUSG00000061462, Obscn, obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF, [Score=84.7, Expect=8e-17]; ENSMUSG00000058056, Palld, palladin, cytoskeletal associated protein, [Score=81.6, Expect=4e-16]; ENSMUSG00000026207, Speg, SPEG complex locus, [Score=80.9, Expect=9e-16]} {Dmel: FBgn0052311, zormin, [Score=102, Expect=7e-23]} {Celegans: WBGene00006820, unc-89, Muscle M-line assembly protein unc-89, [Score=77.4, Expect=8e-15]} {Smed: dd_Smed_v6_13910_0_1, dd_Smed_v6_13910_0_1, [Score=127, Expect=3e-31]} {RNA1509_44395} {RNA1310_15128.1, RNA1509_44395} {RNA1509_44395, RNA815_29263} |
| 43. | MligTC455_53199 | 76 | 1.58 | Mlig455_035187 | Neo: - Age: Up-Down-Down |
1.705 | - | 0.737 | - | - | 0.968 | - | Mlig455_035187 {REF} {Length: 4248} {Pfam: MyTH4 domain [PF00784.19, score=60.4]} {Smed: dd_Smed_v6_19214_0_1, dd_Smed_v6_19214_0_1, [RH, Score=172, Expect=1e-46]} {RNA1310_70974} {RNA815_46536} | |
| 44. | MligTC455_20769 | 86 | 1.8 | Mlig455_058483 | Neo: - Age: Up-Down-Down |
CALCR | 1.704 | - | - | 0.744 | - | 0.960 | - | Mlig455_058483 {REF} {Length: 1844} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=149.2]; Hormone receptor domain [PF02793.24, score=37.6]} {Human: ENSG00000004948, CALCR, calcitonin receptor, [Score=140, Expect=3e-36]} {Mouse: ENSMUSG00000023964, Calcr, calcitonin receptor, [Score=147, Expect=1e-38]} {Dmel: FBgn0260753, Pdfr, Pigment-dispersing factor receptor, [Score=213, Expect=5e-62]} {Celegans: WBGene00015735, pdfr-1, Calcitonin receptor-like protein 1, [Score=178, Expect=4e-50]} {Smed: dd_Smed_v6_22246_0_1, dd_Smed_v6_22246_0_1, [RH, Score=199, Expect=4e-59]} {RNA1310_16931.2} {RNA815_17279} |
| 45. | MligTC455_46885 | 72 | 1.49 | Mlig455_015138 | Neo: - Age: - |
PRKG2 | 1.691 | - | - | - | 0.733 | 0.958 | - | Mlig455_015138 {REF} {Length: 3064} {Pfam: Protein kinase domain [PF00069.27, score=227.4]; Cyclic nucleotide-binding domain [PF00027.31, score=128.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=118.5]; Kinase-like [PF14531.8, score=25.1]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=674, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=674, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=682, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=668, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=676, Expect=0.0]} {RNA1509_26653} {RNA1310_15330.1} {RNA815_26005} |
| 46. | MligTC455_40596 | 131 | 2.74 | Mlig455_029755, Mlig455_029759, Mlig455_029851 | Neo: - Age: - |
PCDH17, PCDH9 | 1.683 | - | 0.731 | - | - | 0.952 | - | Mlig455_029755 {REF} {Length: 3844} {Pfam: Cadherin domain [PF00028.19, score=281.1]; Cadherin-like [PF08266.14, score=32.1]; Cadherin-like [PF16184.7, score=23.9]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=239, Expect=6e-64]; ENSG00000169851, PCDH7, protocadherin 7, [Score=228, Expect=1e-60]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=236, Expect=3e-63]; ENSMUSG00000029108, Pcdh7, protocadherin 7, [Score=227, Expect=1e-60]} {Dmel: FBgn0284247, ds, dachsous, [Score=227, Expect=4e-60]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_2654_0_1, dd_Smed_v6_2654_0_1, [Score=251, Expect=4e-69]} {RNA1509_47646} {RNA1310_26844} {RNA815_60336} Mlig455_029759 {REF} {Length: 2237} {Pfam: Cadherin domain [PF00028.19, score=169.5]; Cadherin-like [PF16184.7, score=19.9]} {Human: ENSG00000118946, PCDH17, protocadherin 17, [Score=190, Expect=5e-51]; ENSG00000177839, PCDHB9, protocadherin beta 9, [Score=181, Expect=2e-48]} {Mouse: ENSMUSG00000035566, Pcdh17, protocadherin 17, [Score=189, Expect=1e-50]; ENSMUSG00000047307, Pcdhb13, protocadherin beta 13, [Score=187, Expect=1e-50]; ENSMUSG00000045689, Pcdhb4, protocadherin beta 4, [Score=185, Expect=9e-50]; ENSMUSG00000063687, Pcdhb5, protocadherin beta 5, [Score=184, Expect=2e-49]; ENSMUSG00000102222, Pcdhga10, protocadherin gamma subfamily A, 10, [Score=182, Expect=2e-48]; ENSMUSG00000045876, Pcdhb8, protocadherin beta 8, [Score=180, Expect=4e-48]} {Dmel: FBgn0284247, ds, dachsous, [Score=158, Expect=3e-40]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=126, Expect=5e-30]} {Smed: dd_Smed_v6_15376_0_1, dd_Smed_v6_15376_0_1, [Score=192, Expect=3e-52]} {RNA1509_47646} {RNA1310_26844} {RNA815_60336} Mlig455_029851 {REF} {Length: 4327} {Pfam: Cadherin domain [PF00028.19, score=280.6]; Cadherin-like [PF08266.14, score=32.2]; Cadherin-like [PF16184.7, score=23.7]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=237, Expect=2e-63]; ENSG00000169851, PCDH7, protocadherin 7, [Score=226, Expect=3e-60]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=234, Expect=1e-63]; ENSMUSG00000029108, Pcdh7, protocadherin 7, [Score=225, Expect=5e-60]} {Dmel: FBgn0284247, ds, dachsous, [Score=226, Expect=7e-60]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=169, Expect=4e-42]} {Smed: dd_Smed_v6_11605_0_1, dd_Smed_v6_11605_0_1, [Score=250, Expect=8e-69]} {RNA1509_47646} {RNA1310_26844, RNA1509_47646} {RNA1509_47646, RNA815_60336} |
| 47. | MligTC455_18384 | 52 | 1.08 | Mlig455_033464, Mlig455_033480 | Neo: - Age: - |
CHRNB3 | 1.682 | - | - | - | 0.710 | 0.972 | - | Mlig455_033464 {REF} {Length: 3273} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=101.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.0]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=112, Expect=2e-26]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=107, Expect=4e-25]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=102, Expect=2e-23]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=95.5, Expect=5e-21]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=98.2, Expect=5e-22]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=90.5, Expect=1e-19]} {RNA1509_28510} {RNA1310_44183.1} {RNA815_32188} Mlig455_033480 {REF} {Length: 904} {RNA1310_131495} |
| 48. | MligTC455_02931 | 215 | 4.47 | Mlig455_007216, Mlig455_007226, Mlig455_007449 | Neo: - Age: - |
DACH1 | 1.671 | - | - | 0.719 | - | 0.952 | - | Mlig455_007216 {REF} {Length: 1825} {Pfam: SKI/SNO/DAC family [PF02437.19, score=116.5]} {Human: ENSG00000276644, DACH1, dachshund family transcription factor 1, [RH, Score=213, Expect=6e-60]} {Mouse: ENSMUSG00000055639, Dach1, dachshund family transcription factor 1, [RH, Score=213, Expect=5e-60]} {Dmel: FBgn0005677, dac, dachshund, [RH, Score=193, Expect=5e-52]} {Celegans: WBGene00000895, dac-1, DAChsund transcription factor homolog, [RH, Score=164, Expect=1e-44]} {Smed: dd_Smed_v6_14598_0_1, dd_Smed_v6_14598_0_1, [RH, Score=237, Expect=9e-71]} {RNA1310_26896.1} {RNA815_36501} Mlig455_007226 {REF} {Length: 2460} {Pfam: SKI/SNO/DAC family [PF02437.19, score=117.2]} {Human: ENSG00000276644, DACH1, dachshund family transcription factor 1, [RH, Score=213, Expect=9e-62]} {Mouse: ENSMUSG00000055639, Dach1, dachshund family transcription factor 1, [RH, Score=212, Expect=7e-62]} {Dmel: FBgn0005677, dac, dachshund, [RH, Score=191, Expect=2e-53]} {Celegans: WBGene00000895, dac-1, DAChsund transcription factor homolog, [RH, Score=163, Expect=7e-46]} {Smed: dd_Smed_v6_14598_0_1, dd_Smed_v6_14598_0_1, [RH, Score=236, Expect=1e-72]} {RNA1310_26896.1} {RNA815_23939} Mlig455_007449 {REF} {Length: 2275} {Pfam: SKI/SNO/DAC family [PF02437.19, score=116.6]} {Human: ENSG00000276644, DACH1, dachshund family transcription factor 1, [RH, Score=213, Expect=1e-59]} {Mouse: ENSMUSG00000055639, Dach1, dachshund family transcription factor 1, [RH, Score=212, Expect=6e-60]} {Dmel: FBgn0005677, dac, dachshund, [RH, Score=192, Expect=8e-52]} {Celegans: WBGene00000895, dac-1, DAChsund transcription factor homolog, [RH, Score=163, Expect=1e-44]} {Smed: dd_Smed_v6_14598_0_1, dd_Smed_v6_14598_0_1, [RH, Score=236, Expect=2e-70]} {RNA1310_26896.1} {RNA815_23939} |
| 49. | MligTC455_33813 | 325 | 6.77 | Mlig455_009548 | Neo: - Age: - |
MOXD1 | 1.664 | 0.707 | - | - | - | 0.957 | - | Mlig455_009548 {REF} {Length: 2790} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=105.1]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=67.2]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=130, Expect=5e-31]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=142, Expect=3e-35]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=116, Expect=7e-27]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=129, Expect=2e-31]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=119, Expect=3e-29]} {RNA1509_41983} {RNA1310_8990} {RNA815_3230} |
| 50. | MligTC455_27785 | 115 | 2.39 | Mlig455_001141 | Neo: - |
HMCN2 | 1.663 | - | - | 0.713 | - | 0.950 | - | Mlig455_001141 {REF} {Length: 2156} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=6e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_38050} {RNA1310_19586} {RNA815_17693} |
| 51. | MligTC455_32501 | 34 | 0.71 | Mlig455_053552 | Neo: - Age: - Region-enriched R2: 9.313/0.01306 |
GRIA1 | 1.66 | - | - | - | 0.708 | 0.952 | - | Mlig455_053552 {REF} {Length: 4329} {Pfam: Ligand-gated ion channel [PF00060.28, score=197.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=125.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=87.5]; Receptor family ligand binding region [PF01094.30, score=76.3]} {Human: ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [RH, Score=605, Expect=0.0]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [RH, Score=577, Expect=0.0]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [RH, Score=577, Expect=0.0]} {Mouse: ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [RH, Score=603, Expect=0.0]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [RH, Score=582, Expect=0.0]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [RH, Score=576, Expect=0.0]} {Dmel: FBgn0004619, GluRIA, Glutamate receptor IA, [RH, Score=499, Expect=6e-161]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [RH, Score=504, Expect=2e-163]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [RH, Score=740, Expect=0.0]} {RNA1509_47919} {RNA1310_3776} {RNA815_11355.1} |
| 52. | MligTC455_46124 | 679 | 14.14 | Mlig455_058018 | Neo: - |
1.659 | - | 0.954 | - | - | 0.705 | - | Mlig455_058018 {REF} {Length: 2266} {Pfam: PLAC8 family [PF04749.19, score=68.6]} {Smed: dd_Smed_v6_477_0_1, dd_Smed_v6_477_0_1, [Score=121, Expect=4e-37]} {RNA1509_56540} {RNA1310_30391} {RNA815_19375} | |
| 53. | MligTC455_16975 | 57 | 1.18 | Mlig455_058291 | Neo: - Age: - |
1.655 | 0.702 | - | - | - | 0.953 | - | Mlig455_058291 {REF} {Length: 3460} {RNA1509_57514} {RNA1310_36771} {RNA815_52846} | |
| 54. | MligTC455_53448 | 71 | 1.47 | Mlig455_060600, Mlig455_060641 | Neo: - Age: Down-Down-Up |
SLC17A6 | 0.983 | - | - | - | - | 0.983 | - | Mlig455_060600 {REF} {Length: 2712} {Pfam: Major Facilitator Superfamily [PF07690.18, score=96.4]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=166, Expect=1e-45]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=158, Expect=6e-43]} {Mouse: ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=166, Expect=8e-46]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=163, Expect=7e-45]; ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=158, Expect=5e-43]} {Dmel: FBgn0038799, MFS9, Major Facilitator Superfamily Transporter 9, [Score=139, Expect=1e-36]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=134, Expect=8e-35]} {Smed: dd_Smed_v6_15146_0_1, dd_Smed_v6_15146_0_1, [Score=462, Expect=9e-162]} {RNA1310_51174} {RNA815_38568} Mlig455_060641 {REF} {Length: 2533} {Pfam: Major Facilitator Superfamily [PF07690.18, score=78.4]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=114, Expect=3e-27]; ENSG00000119899, SLC17A5, solute carrier family 17 member 5, [Score=110, Expect=3e-26]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=110, Expect=6e-26]} {Mouse: ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=115, Expect=6e-28]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=114, Expect=2e-27]; ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=112, Expect=7e-27]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=103, Expect=7e-24]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=103, Expect=4e-24]} {Smed: dd_Smed_v6_15146_0_1, dd_Smed_v6_15146_0_1, [Score=333, Expect=5e-111]} {RNA1310_51174} {RNA815_38568} |
| 55. | MligTC455_17644 | 182 | 3.8 | Mlig455_007930, Mlig455_008033 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_007930 {REF} {Length: 2086} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.9]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=3e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} Mlig455_008033 {REF} {Length: 1974} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.6]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=4e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} |
|
| 56. | MligTC455_30908 | 575 | 11.98 | Mlig455_034385 | Neo: - Age: - |
RBMS2 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_034385 {REF} {Length: 4835} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=55.7]} {Human: ENSG00000076067, RBMS2, RNA binding motif single stranded interacting protein 2, [RH, Score=120, Expect=2e-28]; ENSG00000144642, RBMS3, RNA binding motif single stranded interacting protein 3, [RH, Score=114, Expect=2e-26]} {Mouse: ENSMUSG00000040043, Rbms2, RNA binding motif, single stranded interacting protein 2, [RH, Score=120, Expect=5e-29]; ENSMUSG00000026970, Rbms1, RNA binding motif, single stranded interacting protein 1, [RH, Score=114, Expect=1e-26]} {Dmel: FBgn0052423, shep, alan shepard, [RH, Score=105, Expect=2e-23]} {Celegans: WBGene00006331, sup-26, SUPpressor, [Score=111, Expect=1e-26]} {Smed: dd_Smed_v6_2612_0_2, dd_Smed_v6_2612_0_2, [RH, Score=111, Expect=3e-25]} {RNA1509_833} {RNA1310_3706.1} {RNA815_5711} |
| 57. | MligTC455_53118 | 133 | 2.76 | Mlig455_029477 | Neo: - Age: - |
CHRNA2 | 0.976 | - | - | - | - | 0.976 | - | Mlig455_029477 {REF} {Length: 3006} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=160.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.2]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=212, Expect=1e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=210, Expect=4e-59]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=209, Expect=3e-59]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=207, Expect=2e-59]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=204, Expect=1e-58]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=204, Expect=4e-58]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=208, Expect=1e-57]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=202, Expect=2e-57]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=437, Expect=6e-147]} {RNA1509_18288} {RNA1310_21192} {RNA815_24334} |
| 58. | MligTC455_22913 | 81 | 1.68 | Mlig455_017659 | Neo: - Age: logFC(26M/2M)=-0.830 |
POMGNT1 | 0.975 | - | - | - | - | 0.975 | - | Mlig455_017659 {REF} {Length: 3196} {Pfam: GNT-I family [PF03071.17, score=58.4]; Interleukin-like EMT inducer [PF15711.7, score=20.9]} {Human: ENSG00000085998, POMGNT1, protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-), [Score=195, Expect=2e-53]} {Mouse: ENSMUSG00000028700, Pomgnt1, protein O-linked mannose beta 1,2-N-acetylglucosaminyltransferase, [Score=195, Expect=1e-53]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=69.7, Expect=3e-12]} {Celegans: WBGene00001638, gly-13, Putative alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, [Score=52.8, Expect=5e-07]} {Smed: dd_Smed_v6_17617_0_1, dd_Smed_v6_17617_0_1, [RH, Score=189, Expect=6e-52]} {RNA1310_17377} {RNA815_13131} |
| 59. | MligTC455_23099 | 185 | 3.85 | Mlig455_048061 | Neo: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_048061 {REF} {Length: 713} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452} {RNA815_4585} | |
| 60. | MligTC455_35627 | 10 | 0.22 | Mlig455_034447 | Neo: - Age: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_034447 {REF} {Length: 2136} {NoTransDecoderORF} {RNA1310_24457} {RNA815_54561} | |
| 61. | MligTC455_23809 | 119 | 2.47 | Mlig455_065200 | Neo: - Age: - |
0.973 | - | - | - | - | 0.973 | - | Mlig455_065200 {REF} {Length: 2060} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=33.7]} {RNA1509_46843} {RNA1310_11232} {RNA815_41042} | |
| 62. | MligTC455_29432 | 12 | 0.25 | Mlig455_010925, Mlig455_033161 | Neo: - Age: Up-Down-Down |
STON2 | 0.973 | - | - | - | - | 0.973 | - | Mlig455_010925 {REF} {Length: 8069} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=150.8]} {Human: ENSG00000140022, STON2, stonin 2, [RH, Score=281, Expect=1e-77]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [RH, Score=283, Expect=5e-79]} {Dmel: FBgn0016975, stnB, stoned B, [RH, Score=381, Expect=2e-109]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [RH, Score=370, Expect=6e-104]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [RH, Score=774, Expect=0.0]} {RNA1509_18728} {RNA1310_1460} {RNA815_11684} Mlig455_033161 {REF} {Length: 6984} {Pfam: Adaptor complexes medium subunit family [PF00928.23, score=18.6]} {Human: ENSG00000140022, STON2, stonin 2, [Score=103, Expect=1e-21]} {Mouse: ENSMUSG00000020961, Ston2, stonin 2, [Score=102, Expect=2e-21]} {Dmel: FBgn0016975, stnB, stoned B, [Score=124, Expect=4e-28]} {Celegans: WBGene00006777, unc-41, Putative stoned B-like protein, [Score=144, Expect=3e-34]} {Smed: dd_Smed_v6_6859_0_1, dd_Smed_v6_6859_0_1, [Score=375, Expect=3e-108]} {RNA1509_18728} {RNA1310_1460} {RNA815_11684} |
| 63. | MligTC455_36248 | 293 | 6.1 | Mlig455_047225 | Neo: - Age: - |
CEP170 | 0.973 | - | - | - | - | 0.973 | - | Mlig455_047225 {REF} {Length: 7154} {TRANSSPLICED} {Pfam: FHA domain [PF00498.28, score=63.8]; Inner membrane component of T3SS, cytoplasmic domain [PF16697.7, score=33.4]} {Human: ENSG00000276725, CEP170, centrosomal protein 170, [Score=96.7, Expect=3e-19]; ENSG00000143702, CEP170, centrosomal protein 170, [Score=96.7, Expect=3e-19]} {Mouse: ENSMUSG00000057335, Cep170, centrosomal protein 170, [Score=100, Expect=1e-20]} {Smed: dd_Smed_v6_9728_0_2, dd_Smed_v6_9728_0_2, [RH, Score=92.0, Expect=1e-18]} {RNA1509_35531, RNA1509_47933} {RNA1310_31312, RNA1509_47933} {RNA1509_47933, RNA815_29466} |
| 64. | MligTC455_38967 | 71 | 1.48 | Mlig455_060741 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.569 Region-enriched R2: 3.815/0.00926 |
UTRN | 0.973 | - | - | - | - | 0.973 | - | Mlig455_060741 {REF} {Length: 4727} {Pfam: EF-hand [PF09069.13, score=127.4]; EF hand [PF09068.13, score=102.4]; Zinc finger, ZZ type [PF00569.19, score=37.7]; WW domain [PF00397.28, score=18.6]} {Human: ENSG00000152818, UTRN, utrophin, [RH, Score=493, Expect=5e-147]; ENSG00000198947, DMD, dystrophin, [RH, Score=489, Expect=1e-150]} {Mouse: ENSMUSG00000019820, Utrn, utrophin, [RH, Score=493, Expect=2e-156]; ENSMUSG00000045103, Dmd, dystrophin, muscular dystrophy, [RH, Score=487, Expect=3e-145]} {Dmel: FBgn0260003, Dys, Dystrophin, [RH, Score=516, Expect=4e-155]} {Celegans: WBGene00001131, dys-1, Dystrophin-1, [RH, Score=337, Expect=1e-95]} {Smed: dd_Smed_v6_5325_0_6, dd_Smed_v6_5325_0_6, [RH, Score=295, Expect=4e-82]} {RNA1509_38827} {RNA1310_24533} {RNA815_12379} |
| 65. | MligTC455_15212 | 12 | 0.26 | Mlig455_059838 | Neo: - Age: - |
ADRA2A | 0.972 | - | - | - | - | 0.972 | - | Mlig455_059838 {REF} {Length: 2182} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=239.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=36.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.6]; Olfactory receptor [PF13853.8, score=28.5]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=200, Expect=2e-57]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=198, Expect=1e-56]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=185, Expect=5e-51]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=195, Expect=5e-56]} {Smed: dd_Smed_v6_19063_0_1, dd_Smed_v6_19063_0_1, [Score=235, Expect=1e-71]} |
| 66. | MligTC455_41919 | 125 | 2.61 | Mlig455_048053 | Neo: - Age: Up-Down-Up Region-enriched R2: 4.173/0.00312 |
0.971 | - | - | - | - | 0.971 | - | Mlig455_048053 {REF} {Length: 2537} {Pfam: Innexin [PF00876.20, score=331.0]} {Dmel: FBgn0265274, Inx3, Innexin 3, [Score=88.2, Expect=1e-18]} {Celegans: WBGene00006749, unc-9, Innexin unc-9, [Score=254, Expect=8e-80]} {Smed: dd_Smed_v6_8019_0_1, dd_Smed_v6_8019_0_1, [Score=296, Expect=3e-95]} {RNA1509_58318} {RNA1310_9243} {RNA815_4486.1} | |
| 67. | MligTC455_14176 | 30 | 0.63 | Mlig455_058283 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_058283 {REF} {Length: 1230} {NoTransDecoderORF} {RNA1509_16231} {RNA1310_87164} {RNA815_8904.1} | |
| 68. | MligTC455_22403 | 76 | 1.58 | Mlig455_043840, Mlig455_047410 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_043840 {REF} {Length: 1721} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Smed: dd_Smed_v6_43697_0_1, dd_Smed_v6_43697_0_1, [Score=84.3, Expect=4e-19]} {RNA1310_93309} {RNA815_54296} Mlig455_047410 {REF} {Length: 1771} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.6]} {Smed: dd_Smed_v6_43697_0_1, dd_Smed_v6_43697_0_1, [Score=84.3, Expect=4e-19]} {RNA1310_96760.2} {RNA815_54296} |
|
| 69. | MligTC455_07793 | 12 | 0.25 | Mlig455_019337, Mlig455_019550 | Neo: - Age: - |
MTNR1A | 0.968 | - | - | - | - | 0.968 | - | Mlig455_019337 {REF} {Length: 1064} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=111.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=20.2]} {Human: ENSG00000168412, MTNR1A, melatonin receptor 1A, [Score=75.9, Expect=9e-15]; ENSG00000170214, ADRA1B, adrenoceptor alpha 1B, [Score=73.6, Expect=1e-13]} {Mouse: ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=81.3, Expect=1e-16]} {Smed: dd_Smed_v6_65999_0_1, dd_Smed_v6_65999_0_1, [Score=161, Expect=7e-47]} {RNA1310_50451} {RNA815_24786} Mlig455_019550 {REF} {Length: 1715} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=111.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=19.8]} {Human: ENSG00000168412, MTNR1A, melatonin receptor 1A, [Score=75.5, Expect=1e-14]; ENSG00000170214, ADRA1B, adrenoceptor alpha 1B, [Score=73.2, Expect=1e-13]} {Mouse: ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=80.9, Expect=1e-16]} {Smed: dd_Smed_v6_65999_0_1, dd_Smed_v6_65999_0_1, [Score=160, Expect=1e-46]} {RNA1509_38799} {RNA1310_50451} {RNA815_24786} |
| 70. | MligTC455_14500 | 10 | 0.21 | Mlig455_017108 | Neo: - Age: Down-Up-Up |
SSTR1 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_017108 {REF} {Length: 2868} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=119.2]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=115, Expect=8e-28]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=116, Expect=4e-28]} {Dmel: FBgn0036789, AstC-R2, Allatostatin C receptor 2, [Score=121, Expect=2e-29]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [RH, Score=112, Expect=2e-26]} {Smed: dd_Smed_v6_14519_0_1, dd_Smed_v6_14519_0_1, [Score=122, Expect=1e-30]} {RNA1310_55087} {RNA815_31043} |
| 71. | MligTC455_16844 | 22 | 0.47 | Mlig455_032383 | Neo: - Age: - |
NPY1R | 0.966 | - | - | - | - | 0.966 | - | Mlig455_032383 {REF} {Length: 1642} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=126.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.7]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=111, Expect=2e-26]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=110, Expect=3e-26]; ENSMUSG00000048337, Npy4r, neuropeptide Y receptor Y4, [Score=108, Expect=1e-25]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=152, Expect=8e-41]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=135, Expect=4e-35]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=216, Expect=3e-65]} {RNA1310_56955} |
| 72. | MligTC455_17596 | 37 | 0.77 | Mlig455_007172 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_007172 {REF} {Length: 1102} {RNA1509_49095} {RNA1310_50088} {RNA815_56889.1} | |
| 73. | MligTC455_38175 | 39 | 0.81 | Mlig455_041332, Mlig455_056218 | Neo: - Age: - |
DNAH9 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_041332 {REF} {Length: 11655} {Pfam: Dynein heavy chain, N-terminal region 1 [PF08385.14, score=560.7]; Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=503.4]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=327.1]; AAA domain (dynein-related subfamily) [PF07728.16, score=68.8]; AAA domain [PF13401.8, score=24.4]; P-loop containing dynein motor region [PF12775.9, score=21.7]; AAA domain [PF13238.8, score=21.3]; AAA ATPase domain [PF13191.8, score=19.6]} {Human: ENSG00000007174, DNAH9, dynein axonemal heavy chain 9, [Score=2544, Expect=0.0]; ENSG00000187775, DNAH17, dynein axonemal heavy chain 17, [Score=2525, Expect=0.0]} {Mouse: ENSMUSG00000056752, Dnah9, dynein, axonemal, heavy chain 9, [Score=2547, Expect=0.0]; ENSMUSG00000033987, Dnah17, dynein, axonemal, heavy chain 17, [Score=2516, Expect=0.0]} {Dmel: FBgn0013812, Dhc93AB, Dynein heavy chain at 93AB, [Score=2306, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=573, Expect=8e-167]} {Smed: dd_Smed_v6_3670_0_1, dd_Smed_v6_3670_0_1, [Score=2819, Expect=0.0]} {RNA1509_7397} {RNA1310_128.1} {RNA815_30.1} Mlig455_056218 {REF} {Length: 12040} {Pfam: Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=505.5]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=433.1]; P-loop containing dynein motor region [PF12775.9, score=256.0]; Dynein heavy chain AAA lid domain [PF17852.3, score=97.3]; AAA domain (dynein-related subfamily) [PF07728.16, score=87.1]; AAA domain [PF13401.8, score=29.7]; AAA ATPase domain [PF13191.8, score=29.6]; AAA domain [PF13604.8, score=25.4]; AAA domain [PF13245.8, score=25.3]; Sigma-54 interaction domain [PF00158.28, score=22.2]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=21.7]; AAA domain [PF13238.8, score=20.7]; Sigma-54 interaction domain [PF14532.8, score=19.9]} {Human: ENSG00000007174, DNAH9, dynein axonemal heavy chain 9, [Score=2583, Expect=0.0]; ENSG00000187775, DNAH17, dynein axonemal heavy chain 17, [Score=2573, Expect=0.0]} {Mouse: ENSMUSG00000033987, Dnah17, dynein, axonemal, heavy chain 17, [Score=2600, Expect=0.0]; ENSMUSG00000056752, Dnah9, dynein, axonemal, heavy chain 9, [Score=2590, Expect=0.0]} {Dmel: FBgn0013812, Dhc93AB, Dynein heavy chain at 93AB, [Score=2405, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=632, Expect=0.0]} {Smed: dd_Smed_v6_3670_0_1, dd_Smed_v6_3670_0_1, [Score=2818, Expect=0.0]} {RNA1509_140, RNA1509_15019} {RNA1310_737, RNA1509_15019} {RNA1509_15019, RNA815_30.1} |
| 74. | MligTC455_48256 | 51 | 1.07 | Mlig455_007665 | Neo: - Age: Down-Up-Down |
0.966 | - | - | - | - | 0.966 | - | Mlig455_007665 {REF} {Length: 4291} {Pfam: EF-hand domain pair [PF13833.8, score=30.9]; EF hand [PF00036.34, score=25.2]; EF-hand domain pair [PF13499.8, score=21.4]; RhoGEF domain [PF00621.22, score=21.0]; EF hand [PF13202.8, score=18.1]} {RNA1509_8417} {RNA1310_24185} {RNA815_18042.1} | |
| 75. | MligTC455_51398 | 351 | 7.32 | Mlig455_000583 | Neo: - Age: - |
KCNT1 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_000583 {REF} {Length: 4688} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=91.5]; Ion channel [PF07885.18, score=43.5]} {Human: ENSG00000107147, KCNT1, potassium sodium-activated channel subfamily T member 1, [RH, Score=1147, Expect=0.0]; ENSG00000162687, KCNT2, potassium sodium-activated channel subfamily T member 2, [RH, Score=1132, Expect=0.0]} {Mouse: ENSMUSG00000052726, Kcnt2, potassium channel, subfamily T, member 2, [RH, Score=1132, Expect=0.0]; ENSMUSG00000058740, Kcnt1, potassium channel, subfamily T, member 1, [RH, Score=1120, Expect=0.0]} {Dmel: FBgn0261698, SLO2, slowpoke 2, [RH, Score=838, Expect=0.0]} {Celegans: WBGene00004831, slo-2, SLO-2 potassium channel; SLOwpoke potassium channel family, [RH, Score=848, Expect=0.0]} {Smed: dd_Smed_v6_9739_0_1, dd_Smed_v6_9739_0_1, [RH, Score=1364, Expect=0.0]} {RNA1509_10851} {RNA1310_11341} {RNA815_3987} |
| 76. | MligTC455_21074 | 844 | 17.59 | Mlig455_070329 | Neo: - Age: - |
DNAAF5 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_070329 {REF} {Length: 3190} {Pfam: HEAT-like repeat [PF13513.8, score=59.4]; HEAT repeats [PF13646.8, score=54.0]; HEAT repeat [PF02985.24, score=49.5]; Vacuolar 14 Fab1-binding region [PF12755.9, score=45.4]; non-SMC mitotic condensation complex subunit 1 [PF12717.9, score=44.4]; CLASP N terminal [PF12348.10, score=24.7]; Armadillo/beta-catenin-like repeat [PF00514.25, score=19.5]; Tti2 family [PF10521.11, score=19.5]} {Human: ENSG00000164818, DNAAF5, dynein axonemal assembly factor 5, [RH, Score=454, Expect=3e-146]} {Mouse: ENSMUSG00000025857, Dnaaf5, dynein, axonemal assembly factor 5, [RH, Score=448, Expect=6e-144]} {Dmel: FBgn0051320, HEATR2, HEAT repeat containing 2, [RH, Score=179, Expect=3e-46]} {Smed: dd_Smed_v6_9203_0_1, dd_Smed_v6_9203_0_1, [RH, Score=452, Expect=5e-146]} {RNA1509_15183, RNA1509_33669} {RNA1310_4698, RNA1509_15183, RNA1509_33669} {RNA1509_15183, RNA1509_33669, RNA815_12543} |
| 77. | MligTC455_07327 | 46 | 0.95 | Mlig455_001874, Mlig455_001949 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_001874 {REF} {Length: 1082} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.3]} {Celegans: WBGene00019444, frpr-11, FMRFamide Peptide Receptor family, [Score=47.8, Expect=7e-06]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [Score=57.4, Expect=3e-09]} {RNA1310_94087} {RNA815_48529} Mlig455_001949 {REF} {Length: 2058} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.4]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [Score=57.0, Expect=4e-09]} {RNA1509_46461} {RNA1310_94087} {RNA815_57978} |
|
| 78. | MligTC455_49654 | 318 | 6.63 | Mlig455_060646 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_060646 {REF} {Length: 1858} {TRANSSPLICED} {Pfam: CD20-like family [PF04103.17, score=21.1]} {RNA1509_55295} {RNA1310_18318, RNA1509_55295} {RNA1509_55295, RNA815_18731} | |
| 79. | MligTC455_51382 | 250 | 5.2 | Mlig455_024597 | Neo: - Age: Down-Up-Up |
0.961 | - | - | - | 0.961 | - | - | Mlig455_024597 {REF} {Length: 2189} {Smed: dd_Smed_v6_14508_0_1, dd_Smed_v6_14508_0_1, [RH, Score=73.2, Expect=5e-15]} {RNA1509_27432} {RNA1310_28268} {RNA815_20912} | |
| 80. | MligTC455_26652 | 30 | 0.63 | Mlig455_036452 | Neo: - Age: - |
NR2E1 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_036452 {REF} {Length: 2848} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=99.9]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=55.3]} {Human: ENSG00000112333, NR2E1, nuclear receptor subfamily 2 group E member 1, [Score=139, Expect=2e-35]} {Mouse: ENSMUSG00000019803, Nr2e1, nuclear receptor subfamily 2, group E, member 1, [Score=139, Expect=1e-35]} {Dmel: FBgn0015381, dsf, dissatisfaction, [Score=129, Expect=6e-31]} {Celegans: WBGene00021417, nhr-236, Nuclear Hormone Receptor family, [RH, Score=135, Expect=1e-35]} {Smed: dd_Smed_v6_25420_0_1, dd_Smed_v6_25420_0_1, [RH, Score=182, Expect=3e-50]} {RNA1310_57853} {RNA815_57699} |
| 81. | MligTC455_31174 | 43 | 0.89 | Mlig455_066686 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_066686 {REF} {Length: 1562} {Pfam: Glycosyltransferase family 92 [PF01697.29, score=108.0]; Glycosyl transferase family 2 [PF13704.8, score=25.6]} {Dmel: FBgn0032506, CG9395, [Score=104, Expect=5e-24]} {Celegans: WBGene00012941, Y47D3B.4, [Score=51.6, Expect=5e-07]} {Smed: dd_Smed_v6_5401_0_1, dd_Smed_v6_5401_0_1, [Score=200, Expect=8e-60]} {RNA1310_16379.1} {RNA815_14941.1} | |
| 82. | MligTC455_23141 | 252 | 5.24 | Mlig455_007944 | Neo: - Age: Up-Down-Up |
INSR | 0.959 | - | - | - | - | 0.959 | - | Mlig455_007944 {REF} {Length: 7081} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=291.8]; Protein kinase domain [PF00069.27, score=128.4]; Receptor L domain [PF01030.26, score=118.3]; Furin-like cysteine rich region [PF00757.22, score=79.0]; Fibronectin type III domain [PF00041.23, score=43.4]; Growth factor receptor domain IV [PF14843.8, score=19.7]} {Human: ENSG00000171105, INSR, insulin receptor, [RH, Score=647, Expect=0.0]} {Mouse: ENSMUSG00000005534, Insr, insulin receptor, [RH, Score=641, Expect=0.0]} {Dmel: FBgn0283499, InR, Insulin-like receptor, [RH, Score=334, Expect=6e-93]} {Celegans: WBGene00000898, daf-2, Insulin-like receptor Insulin-like receptor subunit alpha Insulin-like receptor subunit beta, [RH, Score=474, Expect=4e-140]} {Smed: dd_Smed_v6_9006_0_1, dd_Smed_v6_9006_0_1, [RH, Score=516, Expect=4e-158]} {RNA1509_5152} {RNA1310_762.1} {RNA815_285.1} |
| 83. | MligTC455_49123 | 58 | 1.21 | Mlig455_057651 | Neo: - Age: - |
ASIC1 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_057651 {REF} {Length: 2608} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=188.4]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=71.2, Expect=3e-12]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=67.0, Expect=4e-11]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=89.0, Expect=3e-18]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=65.9, Expect=4e-11]} {RNA1310_10141} {RNA815_10820} |
| 84. | MligTC455_21325 | 36 | 0.75 | Mlig455_053949 | Neo: - |
SLC4A10 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_053949 {REF} {Length: 5641} {TRANSSPLICED} {Pfam: HCO3- transporter family [PF00955.23, score=719.0]; Band 3 cytoplasmic domain [PF07565.15, score=297.5]; Sulfate permease family [PF00916.22, score=19.2]} {Human: ENSG00000144290, SLC4A10, solute carrier family 4 member 10, [Score=947, Expect=0.0]; ENSG00000050438, SLC4A8, solute carrier family 4 member 8, [Score=935, Expect=0.0]} {Mouse: ENSMUSG00000023032, Slc4a8, solute carrier family 4 (anion exchanger), member 8, [Score=946, Expect=0.0]; ENSMUSG00000026904, Slc4a10, solute carrier family 4, sodium bicarbonate cotransporter-like, member 10, [Score=946, Expect=0.0]} {Dmel: FBgn0259111, Ndae1, Na[+]-driven anion exchanger 1, [Score=634, Expect=0.0]} {Celegans: WBGene00009920, abts-1, Anion exchange protein, [Score=612, Expect=0.0]} {Smed: dd_Smed_v6_3003_0_2, dd_Smed_v6_3003_0_2, [Score=1208, Expect=0.0]} {RNA1509_21197} {RNA1310_2601, RNA1509_21197} {RNA1509_21197, RNA815_7793.1} |
| 85. | MligTC455_24070 | 770 | 16.04 | Mlig455_038826, Mlig455_038914 | Neo: - Age: Down-Up-Down |
0.958 | - | - | - | - | 0.958 | - | Mlig455_038826 {REF} {Length: 1863} {RNA1509_15528} {RNA1310_31818} {RNA815_10793} Mlig455_038914 {REF} {Length: 2695} {RNA1509_15528} {RNA1310_31818} {RNA815_10793} |
|
| 86. | MligTC455_23048 | 39 | 0.81 | Mlig455_057935, Mlig455_070733 | Neo: - |
SGSM1 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_057935 {REF} {Length: 4312} {Pfam: Rab-GTPase-TBC domain [PF00566.20, score=82.6]; RUN domain [PF02759.21, score=76.3]; Rab-binding domain (RBD) [PF12068.10, score=76.0]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [RH, Score=372, Expect=6e-110]} {Mouse: ENSMUSG00000042216, Sgsm1, small G protein signaling modulator 1, [RH, Score=369, Expect=4e-113]} {Dmel: FBgn0031116, CG1695, [Score=383, Expect=8e-114]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=221, Expect=2e-59]} {Smed: dd_Smed_v6_12130_0_1, dd_Smed_v6_12130_0_1, [Score=479, Expect=3e-150]} {RNA1310_35495.2} {RNA815_26008} Mlig455_070733 {REF} {Length: 1948} {Pfam: Rab-binding domain (RBD) [PF12068.10, score=56.3]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [Score=204, Expect=7e-55]} {Mouse: ENSMUSG00000042216, Sgsm1, small G protein signaling modulator 1, [Score=201, Expect=1e-55]} {Dmel: FBgn0031116, CG1695, [Score=200, Expect=5e-54]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=115, Expect=2e-26]} {Smed: dd_Smed_v6_3307_0_1, dd_Smed_v6_3307_0_1, [Score=188, Expect=3e-50]} {RNA1310_49577} {RNA815_26008} |
| 87. | MligTC455_23479 | 66 | 1.38 | Mlig455_010615 | Neo: - Age: Down-Down-Up |
0.957 | - | - | - | - | 0.957 | - | Mlig455_010615 {REF} {Length: 2310} {RNA1310_33311} {RNA815_31084} | |
| 88. | MligTC455_23834 | 165 | 3.45 | Mlig455_014586 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.373 Region-enriched R8: 3.889/0.00756 |
KY | 0.957 | - | - | - | 0.957 | - | - | Mlig455_014586 {REF} {Length: 3955} {Human: ENSG00000174611, KY, kyphoscoliosis peptidase, [Score=109, Expect=6e-24]} {Mouse: ENSMUSG00000035606, Ky, kyphoscoliosis peptidase, [Score=116, Expect=3e-26]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=144, Expect=1e-34]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=132, Expect=2e-32]} {Smed: dd_Smed_v6_1109_0_1, dd_Smed_v6_1109_0_1, [Score=121, Expect=9e-28]} {RNA1509_33814} {RNA1310_3257} {RNA815_3558} |
| 89. | MligTC455_36159 | 12 | 0.24 | Mlig455_038776, Mlig455_067680 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_038776 {REF} {Length: 1184} {Smed: dd_Smed_v6_47583_0_1, dd_Smed_v6_47583_0_1, [RH, Score=80.9, Expect=3e-18]} Mlig455_067680 {REF} {Length: 5269} {Pfam: Immunoglobulin domain [PF13895.8, score=62.2]; Immunoglobulin domain [PF13927.8, score=45.8]; Immunoglobulin I-set domain [PF07679.18, score=33.0]; F5/8 type C domain [PF00754.27, score=32.4]; Immunoglobulin domain [PF00047.27, score=25.2]; Ig-like C2-type domain [PF06328.13, score=23.4]; Immunoglobulin V-set domain [PF07686.19, score=23.3]; Izumo-like Immunoglobulin domain [PF16706.7, score=23.0]; Sad1 / UNC-like C-terminal [PF07738.15, score=18.8]} {RNA1310_51630} {RNA815_49405} |
|
| 90. | MligTC455_51690 | 58 | 1.2 | Mlig455_031667 | Neo: - Age: - |
CNKSR3 | 0.957 | - | - | - | - | 0.957 | - | Mlig455_031667 {REF} {Length: 3455} {Pfam: SAM domain (Sterile alpha motif) [PF00536.32, score=34.6]; SAM domain (Sterile alpha motif) [PF07647.19, score=33.9]; Connector enhancer of kinase suppressor of ras [PF10534.11, score=24.4]; PDZ domain [PF00595.26, score=19.3]} {Human: ENSG00000153721, CNKSR3, CNKSR family member 3, [Score=79.0, Expect=7e-15]} {Mouse: ENSMUSG00000015202, Cnksr3, Cnksr family member 3, [Score=79.0, Expect=4e-15]} {RNA1509_17630} {RNA1310_4367.2} {RNA815_23045.1} |
| 91. | MligTC455_15015 | 39 | 0.8 | Mlig455_007568 | Neo: - Age: Down-Up-Up |
LHX3 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_007568 {REF} {Length: 2000} {Pfam: LIM domain [PF00412.24, score=113.8]; Homeodomain [PF00046.31, score=69.9]; Homeobox KN domain [PF05920.13, score=20.4]; Anti-sigma-K factor rskA [PF10099.11, score=18.9]} {Human: ENSG00000107187, LHX3, LIM homeobox 3, [RH, Score=319, Expect=6e-106]; ENSG00000121454, LHX4, LIM homeobox 4, [RH, Score=311, Expect=1e-102]} {Mouse: ENSMUSG00000026934, Lhx3, LIM homeobox protein 3, [RH, Score=320, Expect=4e-106]; ENSMUSG00000026468, Lhx4, LIM homeobox protein 4, [RH, Score=311, Expect=7e-103]} {Dmel: FBgn0002023, Lim3, [RH, Score=323, Expect=7e-106]} {Celegans: WBGene00000438, ceh-14, Homeobox protein ceh-14, [RH, Score=268, Expect=9e-87]} {Smed: dd_Smed_v6_20755_0_1, dd_Smed_v6_20755_0_1, [RH, Score=328, Expect=4e-111]} {RNA1310_33977} {RNA815_27636} |
| 92. | MligTC455_07053 | 23 | 0.47 | Mlig455_013671 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_013671 {REF} {Length: 343} {RNA1509_19561} {RNA1310_8953} {RNA815_356.1} | |
| 93. | MligTC455_29232 | 131 | 2.72 | Mlig455_050150 | Neo: - Age: - Regeneration-downregulated BL: -4.109 Regeneration-depleted BL: -4.109 |
PCDH9 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_050150 {REF} {Length: 3993} {Pfam: Cadherin domain [PF00028.19, score=289.2]; Cadherin-like [PF08266.14, score=40.2]; Cadherin-like [PF16184.7, score=34.6]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=302, Expect=4e-85]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [RH, Score=307, Expect=1e-86]} {Dmel: FBgn0284247, ds, dachsous, [Score=207, Expect=7e-54]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_21489_0_1, dd_Smed_v6_21489_0_1, [Score=330, Expect=2e-97]} {RNA1310_46914} |
| 94. | MligTC455_27532 | 14 | 0.3 | Mlig455_050096 | Neo: - Age: - |
ITPKA | 0.954 | - | - | - | - | 0.954 | - | Mlig455_050096 {REF} {Length: 2853} {Pfam: Inositol polyphosphate kinase [PF03770.18, score=89.5]} {Human: ENSG00000137825, ITPKA, inositol-trisphosphate 3-kinase A, [Score=206, Expect=4e-60]; ENSG00000143772, ITPKB, inositol-trisphosphate 3-kinase B, [Score=198, Expect=2e-54]} {Mouse: ENSMUSG00000027296, Itpka, inositol 1,4,5-trisphosphate 3-kinase A, [Score=207, Expect=6e-61]; ENSMUSG00000003752, Itpkc, inositol 1,4,5-trisphosphate 3-kinase C, [Score=197, Expect=2e-55]; ENSMUSG00000038855, Itpkb, inositol 1,4,5-trisphosphate 3-kinase B, [Score=197, Expect=4e-54]} {Dmel: FBgn0032147, IP3K1, Inositol 1,4,5-triphosphate kinase 1, [Score=180, Expect=4e-52]} {Celegans: WBGene00002979, lfe-2, Inositol-trisphosphate 3-kinase homolog, [Score=207, Expect=8e-62]} {Smed: dd_Smed_v6_3687_0_2, dd_Smed_v6_3687_0_2, [Score=182, Expect=6e-51]} {RNA1509_15208} {RNA1310_45410.1} {RNA815_8803} |
| 95. | MligTC455_49907 | 79 | 1.65 | Mlig455_059454 | Neo: - Age: Up-Down-Down |
0.954 | - | - | - | - | 0.954 | - | Mlig455_059454 {REF} {Length: 2213} {Pfam: Otopetrin [PF03189.15, score=92.9]} {Dmel: FBgn0259994, CG42492, [Score=79.3, Expect=3e-16]} {Celegans: WBGene00018478, otpl-5, OToPetrin-Like, [Score=75.5, Expect=3e-15]} {Smed: dd_Smed_v6_15458_0_1, dd_Smed_v6_15458_0_1, [Score=90.1, Expect=4e-20]} {RNA1310_31431.1} {RNA815_29709} | |
| 96. | MligTC455_03732 | 6 | 0.12 | Mlig455_030369, Mlig455_030417 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_030369 {REF} {Length: 1440} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=36.0]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=51.6, Expect=3e-07]} {Celegans: WBGene00016149, frpr-3, FMRFamide Peptide Receptor family; VRFamide receptor 1, [Score=53.5, Expect=3e-08]} {Smed: dd_Smed_v6_29019_0_1, dd_Smed_v6_29019_0_1, [Score=116, Expect=2e-30]} Mlig455_030417 {REF} {Length: 2861} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=67.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=32.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.1]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=63.5, Expect=2e-10]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=69.3, Expect=2e-12]} {Smed: dd_Smed_v6_29019_0_1, dd_Smed_v6_29019_0_1, [Score=171, Expect=6e-49]} |
|
| 97. | MligTC455_14896 | 40 | 0.84 | Mlig455_036869 | Neo: - Age: - |
SYT16 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_036869 {REF} {Length: 2103} {TRANSSPLICED} {Pfam: C2 domain [PF00168.32, score=30.7]} {Human: ENSG00000139973, SYT16, synaptotagmin 16, [Score=154, Expect=2e-39]} {Mouse: ENSMUSG00000016200, Syt14, synaptotagmin XIV, [Score=138, Expect=6e-34]} {Dmel: FBgn0261086, Syt14, Synaptotagmin 14, [Score=127, Expect=1e-30]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [Score=57.8, Expect=8e-09]} {Smed: dd_Smed_v6_9164_0_3, dd_Smed_v6_9164_0_3, [Score=115, Expect=1e-27]} {RNA1509_28160} {RNA1310_13696} {RNA815_4420.1} |
| 98. | MligTC455_19389 | 78 | 1.62 | Mlig455_002228 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_002228 {REF} {Length: 1094} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=42.6]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [Score=97.1, Expect=1e-22]} {RNA1509_55345} {RNA1310_104122} {RNA815_37548} | |
| 99. | MligTC455_23047 | 66 | 1.36 | Mlig455_057970 | Neo: - Age: Up-Down-Down |
SGSM1 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_057970 {REF} {Length: 4688} {Pfam: Rab-GTPase-TBC domain [PF00566.20, score=83.8]; RUN domain [PF02759.21, score=76.3]; Rab-binding domain (RBD) [PF12068.10, score=74.4]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [RH, Score=370, Expect=4e-109]} {Mouse: ENSMUSG00000042216, Sgsm1, small G protein signaling modulator 1, [RH, Score=367, Expect=4e-112]} {Dmel: FBgn0031116, CG1695, [Score=381, Expect=6e-113]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=219, Expect=1e-58]} {Smed: dd_Smed_v6_12130_0_1, dd_Smed_v6_12130_0_1, [Score=474, Expect=2e-148]} {RNA1310_35495.2} {RNA815_26008} |
| 100. | MligTC455_15215 | 22 | 0.46 | Mlig455_037928 | Neo: - Age: - |
CHRNA9 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_037928 {REF} {Length: 2079} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=180.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=57.1]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=221, Expect=7e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=9e-64]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=222, Expect=1e-65]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=219, Expect=3e-64]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=214, Expect=7e-63]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=228, Expect=2e-65]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=221, Expect=6e-65]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=214, Expect=1e-62]} {RNA1310_88831} |
There are 5 more genes with r >= 0.95